PMC:7228307 / 224-637
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 21 | 359-363 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T2 | 22-36 | Body_part | denotes | immunoglobulin | http://purl.org/sig/ont/fma/fma62871 |
| T3 | 37-42 | Body_part | denotes | (Ig)G | http://purl.org/sig/ont/fma/fma62872 |
| T4 | 38-40 | Body_part | denotes | Ig | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 59-67 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activate |
| T8 | 81-82 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 359-361 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 4-11 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
| T2 | 43-50 | Chemical | denotes | ligands | http://purl.obolibrary.org/obo/CHEBI_52214 |
| T3 | 132-140 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
| T4 | 373-381 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
LitCovid-sample-MedDRA
| Id | Subject | Object | Predicate | Lexical cue | meddra_id |
|---|---|---|---|---|---|
| T1 | 22-36 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | immunoglobulin | http://purl.bioontology.org/ontology/MEDDRA/10021496 |
| T2 | 38-40 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | Ig | http://purl.bioontology.org/ontology/MEDDRA/10021496 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 116-120 | http://purl.obolibrary.org/obo/IDO_0000531 | denotes | host |
| T3 | 141-150 | http://purl.obolibrary.org/obo/BFO_0000034 | denotes | functions |
| T4 | 213-222 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 21 | 359-363 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 224-409 | Sentence | denotes | More than 100 therapeutic monoclonal antibodies (mAbs) are approved or in late stage clinical trials, many of which harness the potent FcγR‐mediated effector systems to varying degrees. |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T2 | 22-36 | Body_part | denotes | immunoglobulin | http://purl.org/sig/ont/fma/fma62871 |
| T3 | 37-42 | Body_part | denotes | (Ig)G | http://purl.org/sig/ont/fma/fma62872 |
| T4 | 38-40 | Body_part | denotes | Ig | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 224-409 | Sentence | denotes | More than 100 therapeutic monoclonal antibodies (mAbs) are approved or in late stage clinical trials, many of which harness the potent FcγR‐mediated effector systems to varying degrees. |